Anesthesia & Analgesia: ”Depth of Anesthesia and Nociception Monitoring: Current State and Vision For 2050.”

Understand the upswing in new monitoring strategies in anesthesia and the key role of NOL monitoring: "Depth of Anesthesia and Nociception Monitoring: Current State and Vision For 2050" (Anesthesia & Analgesia Feb. 2024)

Continue ReadingAnesthesia & Analgesia: ”Depth of Anesthesia and Nociception Monitoring: Current State and Vision For 2050.”

FDA authorizes marketing of Medasense’s NOL (nociception level index) technology through a De Novo grant

Agency clearance paves way for commercialization in the United States of first and only authorized device to measure pain in anesthetized patients undergoing surgery

Continue ReadingFDA authorizes marketing of Medasense’s NOL (nociception level index) technology through a De Novo grant